Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities
Resonetics (NYSE:CG) has acquired Eden Holdings, comprising Eden Manufacturing and Eden Tool, to expand its precision manufacturing capabilities in the medical device sector. The acquisition integrates Eden's expertise in micro-molding, insert-molding, and advanced machining and tooling with Resonetics' established metal processing capabilities.
Eden, founded in 2000, specializes in Class 101 production tooling for the MedTech industry and serves high-growth markets including robotic surgery, minimally invasive surgery, electrophysiology, and rapid diagnostics. The strategic acquisition enhances Resonetics' ability to deliver integrated solutions across materials and technologies for complex medical devices.
Resonetics (NYSE:CG) ha acquisito Eden Holdings, che comprende Eden Manufacturing e Eden Tool, per espandere le proprie capacità di produzione di precisione nel settore dei dispositivi medici. L'acquisizione integra l'expertise di Eden in micro-molding, insert-molding e lavorazioni e utensili avanzati con le consolidate capacità di lavorazione dei metalli di Resonetics.
Eden, fondata nel 2000, è specializzata in strumenti di produzione di classe 101 per l'industria MedTech e serve mercati ad alta crescita tra cui chirurgia robotica, chirurgia minimamente invasiva, elettrofisiologia e diagnostica rapida. L'acquisizione strategica migliora la capacità di Resonetics di offrire soluzioni integrate attraverso materiali e tecnologie per dispositivi medici complessi.
Resonetics (NYSE:CG) ha adquirido Eden Holdings, que incluye Eden Manufacturing y Eden Tool, para ampliar sus capacidades de fabricación de precisión en el sector de dispositivos médicos. La adquisición integra la experiencia de Eden en microinyección, inserción de inyecciones y mecanizado y herramientas avanzadas con las capacidades consolidadas de procesamiento de metales de Resonetics.
Eden, fundada en 2000, se especializa en herramientas de producción de Clase 101 para la industria MedTech y atiende mercados de alto crecimiento como cirugía robótica, cirugía mínimamente invasiva, electrofisiología y diagnóstico rápido. La adquisición estratégica mejora la capacidad de Resonetics para ofrecer soluciones integradas a través de materiales y tecnologías para dispositivos médicos complejos.
Resonetics (NYSE:CG)가 Eden Manufacturing과 Eden Tool을 포함한 Eden Holdings를 인수하여 의료기기 부문의 정밀 제조 능력을 확장했습니다. 이번 인수로 Eden의 마이크로몰딩, 인서트몰딩, 고급 가공 및 공구에 대한 전문 지식이 Resonetics의 확립된 금속 가공 능력과 통합됩니다.
Eden은 2000년에 설립되었으며 MedTech 산업을 위한 클래스 101 생산 도구에 특화되어 로봇 수술, 최소 침습 수술, 전기생리학 및 신속 진단 등 고성장 시장을 대상으로 합니다. 이 전략적 인수는 재료와 기술 전반에 걸쳐 복합 의료 기기에 대해 통합 솔루션을 제공하는 Resonetics의 역량을 강화합니다.
Resonetics (NYSE:CG) a acquis Eden Holdings, qui comprend Eden Manufacturing et Eden Tool, afin d'élargir ses capacités de fabrication de précision dans le secteur des dispositifs médicaux. L'acquisition intègre l'expertise d'Eden en micro-moulage, moulage par insertion et usinage et outillage avancés avec les capacités établies de transformation des métaux de Resonetics.
Eden, fondée en 2000, se spécialise dans les outillages de production de classe 101 pour l'industrie MedTech et dessert des marchés à forte croissance tels que la chirurgie robotique, la chirurgie mini-invasive, l’électrophysiologie et le diagnostic rapide. L'acquisition stratégique améliore la capacité de Resonetics à fournir des solutions intégrées à travers les matériaux et les technologies pour des dispositifs médicaux complexes.
Resonetics (NYSE:CG) hat Eden Holdings übernommen, zu dem Eden Manufacturing und Eden Tool gehören, um seine Fertigungskompetenzen im Bereich medizinischer Geräte zu erweitern. Die Übernahme integriert Edens Expertise in Mikroformen, Insert-Formgebung sowie fortschrittliche Bearbeitung und Werkzeugtechnik mit Resonetics' etablierten Metallbearbeitungsfähigkeiten.
Eden, 2000 gegründet, spezialisiert sich auf Produktionswerkzeuge der Klasse 101 für die MedTech-Industrie und bedient Wachstumsfelder wie robotische Chirurgie, minimalinvasive Chirurgie, Elektro-Physiologie und schnelle Diagnostik. Die strategische Übernahme stärkt Resonetics' Fähigkeit, integrierte Lösungen über Materialien und Technologien hinweg für komplexe medizinische Geräte bereitzustellen.
استولت Resonetics (بورصة نيويورك: CG) على Eden Holdings، التي تضم Eden Manufacturing و Eden Tool، لتوسيع قدراتها في التصنيع الدقيق في قطاع الأجهزة الطبية. تدمج الصفقة خبرة Eden في الحقن الميكروي، وحقن التركيبات، وآلات وأدوات متقدمة مع قدرات المعالجة المعدنية القائمة لدى Resonetics.
تأسست Eden في عام 2000، وتتخصص في أدوات إنتاج من الفئة 101 لصناعة MedTech وتخدم أسواق ذات نمو مرتفع مثل جراحة الروبوت، والجراحة أقل توغلاً، والفيزيولوجيا الكهربائية، والتشخيص السريع. تعزز هذه الاستحواذات الاستراتيجية قدرة Resonetics على تقديم حلول متكاملة عبر المواد والتقنيات لأجهزة طبية معقدة.
Resonetics（NYSE:CG） 已收购 Eden Holdings，其中包括 Eden Manufacturing 与 Eden Tool，以扩大其在医疗器械领域的高精度制造能力。此次收购将 Eden 在 微成型、插入成型以及先进加工与工具方面的专业知识，与 Resonetics 现有的金属加工能力相结合。
Eden 成立于 2000 年，专注于 一级（Class 101）生产工具，服务于 MedTech 行业并覆盖机器人手术、微创手术、电生理学和快速诊断等高增长市场。这一战略收购提升了 Resonetics 提供跨材料、跨技术的复杂医疗器械综合解决方案的能力。
- Strategic expansion into precision micro-molding and tooling capabilities
- Access to high-growth medical device markets including robotic surgery and diagnostics
- Enhanced integrated solutions offering across materials and technologies
- Complementary addition to existing metal processing expertise
- Integration challenges may arise from combining different manufacturing processes
- Potential operational complexity in managing expanded capabilities
Insights
Resonetics expands capabilities with Eden acquisition, strengthening its integrated MedTech manufacturing solutions portfolio.
Resonetics' acquisition of Eden Holdings represents a strategic expansion of its manufacturing capabilities in the medical device sector. This transaction adds critical polymer processing expertise - specifically precision micro-molding, insert molding, and advanced tooling - to complement Resonetics' existing metal processing strengths.
The acquisition creates significant technology synergies by combining Resonetics' metal manufacturing capabilities with Eden's polymer expertise. This enables Resonetics to offer more comprehensive solutions across multiple materials and manufacturing processes - a key competitive advantage when serving medical device OEMs who increasingly seek integrated supply chain partners.
Eden's specialization in Class 101 production tooling (the highest precision classification for molds) and engineering-driven approach positions Resonetics to better serve high-growth medical segments including robotic surgery, minimally invasive procedures, electrophysiology, and rapid diagnostics. These markets demand extremely precise components with complex geometries where Eden has established expertise.
This transaction follows the medical device industry trend of consolidation among specialized manufacturers, as OEMs prefer working with fewer suppliers who can provide more comprehensive solutions. By expanding its polymer capabilities, Resonetics strengthens its position as a differentiated partner for micro-manufacturing of complex medical components.
Acquisition adds precision micro-molding, insert molding, and advanced machining and tooling to Resonetics' portfolio of precision manufacturing capabilities.
Founded in 2000, Eden has built a strong reputation for its expertise in precision tooling and machining, which evolved into high precision micro and insert molding for critical medical devices. The company also specializes in Class 101 production tooling for the MedTech industry, delivering molds and components that demand uncompromising precision, complex geometries, and exceptional quality. Eden's engineering-driven approach to mold design and manufacturing ensures consistent, reliable solutions that meet the rigorous standards of leading MedTech OEMs.
"With the addition of Eden, we are enhancing our ability to deliver integrated solutions across materials and technologies. Eden's strength in injection molding and precision tooling is a critical addition, bringing valuable new capabilities that complement our metal processing expertise across our entire portfolio and enable us to deliver a more integrated offering to our customers," said Kevin Kelly, CEO of Resonetics.
"Joining Resonetics gives Eden access to greater resources and a global platform to better serve our customers. We're excited to combine our precision tooling, insert molding, and micro-molding expertise with Resonetics' advanced technologies to provide even more value to the medical device industry," said David Tomic, President of Eden.
The acquisition of Eden expands Resonetics' polymer capabilities and adds another key area of expertise, reinforcing its position as a differentiated partner delivering micro manufacturing solutions for complex medical devices.
About Resonetics
Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the medical device industry. Resonetics is a leader in laser processing, nitinol manufacturing, thin-wall stainless steel, nitinol & precious metal tubing, and photochemical machining. With strategically located LightSpeed Labs® and AGILE Product Development® centers, Resonetics is committed to quality, speed, innovation, and a great customer experience. The company is ISO 13485:2016 certified with 17 facilities and more than 3,000 associates in
About GTCR
Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Since its inception, GTCR has invested more than
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/resonetics-acquires-eden-holdings-adding-injection-molding-to-its-capabilities-302568600.html
SOURCE Resonetics, LLC
FAQ
What companies did Resonetics (NYSE:CG) acquire in September 2025?
What new capabilities does the Eden acquisition add to Resonetics?
What markets will Resonetics serve with Eden's capabilities?
When was Eden Holdings founded and what is their specialty?
Who will lead Eden after the Resonetics acquisition?
